Pfizer and Arvinas' experimental treatment significantly extends progression-free survival in breast cancer patients with ...

An experimental treatment by Pfizer and Arvinas delayed progression of breast cancer by more than three months compared to ...

While vepdegestrant outperformed a standard treatment option in a subtype of patients, the benefit on progression-free ...

New targeted therapies allow for the treatment of a disease that is already the fifth leading cause of fatal tumors globally ...

The BREAKWATER study enrolled patients with newly diagnosed colon cancer that harbors a mutation called BRAF 600E that makes ...

A medical revolution quietly unfolds on Hainan, allowing patients to access cutting-edge therapies before they hit the market ...

A common class of antidepressant medications might be even more useful than we thought. Research out today suggests that ...

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

In an interview, Aditya Shreenivas, MD, MS, discussed the approval of penpulimab in nasopharyngeal carcinoma and the study ...

Biden released his first statement regarding his diagnosis on Monday. “Cancer touches us all,” the 82-year-old wrote on X.